from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2157c/murF

LFCtreatmentdescriptionclass of inhibitor

1.338

Amikacinug/mL Amikacintranslation

0.000

Cap5-10ug/mL Capreomycintranslation

0.000

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

1.876

Tet5-10 ug/mL Tetracyclinetranslation

1.052

Rif0.2-5ug/mL Rifampicintranscription

0.000

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.694

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.103

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.262

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.126

Clofazimine10-13 ug/mL Clofaziminerespiration

0.838

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.689

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.524

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.573

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.261

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.132

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.282

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.009

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.701

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.530

KCN5-20 ug/mL Potassium cyaniderespiration

-0.111

NaN30.2-2 mM Sodium aziderespiration

-0.363

Nigericin50 uM Nigericinrespiration

0.906

TRC10-150 ug/mL Triclosanrespiration

-1.139

TRZ10-25 ug/mL Thioridazinerespiration

-0.793

Valinomycin0.5-10 uM Valinomycinrespiration

-0.316

ZnSO42 mM ZnSO4respiration

-0.562

menadione6-10 ug/mL Menadionerespiration

0.000

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.728

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

2.842

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.313

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.266

NRP_1Non-replicating persistence stage 1dosRassociated

0.000

Amp0.2mg/mL AmpicillincellWall

-0.117

Cephalexin20-100 ug/mL CephalexincellWall

0.303

Cerulenin0.32-5 ug/mL CerulenincellWall

0.463

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.769

EMB10-20 ug/mL EthambutolcellWall

-0.169

Eta12-40 ug/mL EthionamidecellWall

-2.997

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.362

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.023

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.594

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.077

BZA0.12 mg/mL BenzamidearomaticAmides

-0.033

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.176

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.465

H2O24 mM hydrogen peroxideDNAdamaging

0.000

Levo10 ug/mL LevofloxacinDNAdamaging

-0.754

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.225

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.000

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.406

UVUV-irradiationDNAdamaging

-0.419

ARP41-4 ug/mL Antitubercular compound ARP4?

-2.133

Antimycin12.5-50 ug/mL Antimycin A?

-0.029

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.362

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.495

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.088

PA8240.2-2 ug/mL PA-824?

-0.087

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.579

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.132

Verapamil50 uM Verapamil?

-0.014

mercaptoethanol2 mM 2-Mercaptoethanol?

0.025

methoxatin10-20 ug/mL Methoxatin?